NonprescriptionAnalgesic/Antipyretic Drug Development in Children 2 to Less Than 12 Years of Age

ADEPT-9: Public Workshop on Enhancing Diversity in Therapeutics Development for Pediatric Patients

Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products

Clinical Pharmacology Guidances Advancing Drug Development and Regulatory Assessment

Advancing the Development of Pediatric Therapeutics on Drug Dosing in Pediatric Patients

Defining “Candy-Like” Nonprescription Drug Products

Physiologically Based Biopharmaceutics Modeling (PBBM) Best Practices for Drug Product Quality

Drug Dissolution in Oral Drug Absorption Workshop

Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development Workshop

Application of Artificial Intelligence & Machine Learning for Precision Medicine